Results you can see
EUCRISA was studied in multiple trials, with more than 2,000 people with mild-to-moderate eczema.
In trials of people ages 2 and up, more people using EUCRISA twice daily (32%) achieved clear or almost clear skin vs. those using non-medicated ointment (22%) after 28 days. Some saw clear or almost clear skin in about a week (8 days).
In a trial of people 3 months and older who achieved clear or almost clear skin using EUCRISA twice daily for up to 2 months, some were able to maintain results through one year when applying once daily.
VIEW PHOTOS IN OUR GALLERY BELOW TO SEE RESULTS FROM
CLINICAL TRIALS AND REAL-WORLD PATIENTSPhotos of a patient treated with EUCRISA in a clinical trial.
Individual results may vary. Not everyone will respond to treatment with EUCRISA.
Real EUCRISA patient pictured here.
Individual results may vary. Not everyone will respond to treatment with EUCRISA.
Doctor's instructions were to use a liquid cleanser daily and apply an over-the-counter moisturizer after bathing.
EUCRISA was not studied with moisturizers on the affected skin, but use on the non-affected areas was allowed.
Real EUCRISA patient pictured here.
Individual results may vary. Not everyone will respond to treatment with EUCRISA.
Doctor's instructions were to use a liquid cleanser daily and apply an over-the-counter moisturizer after bathing.
EUCRISA was not studied with moisturizers on the affected skin, but use on the non-affected areas was allowed.
Real EUCRISA patient pictured here.
Individual results may vary. Not everyone will respond to treatment with EUCRISA.
Patient treated with EUCRISA and over-the-counter moisturizers.
EUCRISA was not studied with moisturizers on the affected skin, but use on the non-affected areas was allowed.
Real EUCRISA patient pictured here.
Photos captured within a 28-day period.
Individual results may vary. Not everyone will respond to treatment with EUCRISA.
Basic skin care included daily moisturizer and shower gel.
EUCRISA was not studied with moisturizers on the affected skin, but use on the non-affected areas was allowed.